Inventor · disambiguated record
Hans-Peter Kiem
Also filed as: KIEM HANS-PETER
9 granted patents·17 pending applications·25 citations·filing 2010–2023
81Inventor score
Files withHUTCHINSON FRED CANCER RES10FRED HUTCHINSON CANCER CENTER8SEATTLE CHILDRENS HOSPITAL2ENSOMA INC1Fred Hutchison Cancer Center1
Top patents by PatentIndex Score
26 records- 0191US10350245B2Point-of-care and/or portable platform for gene therapyHUTCHINSON FRED CANCER RES·Filed 2016·Granted Jul 16, 2019·21 cites·17 claims
- 0288US10828333B2Point-of-care and/or portable platform for gene therapyHUTCHINSON FRED CANCER RES·Filed 2019·Granted Nov 10, 2020·4 cites·20 claims
- 0380US12385070B2Homology directed repair compositions for the treatment of hemoglobinopathiesSEATTLE CHILDRENS HOSPITAL·Filed 2023·Granted Aug 12, 2025·0 cites·27 claims
- 0473US12295973B2Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cellsFRED HUTCHINSON CANCER CENTER·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 0562US12110499B2Homology directed repair compositions for the treatment of hemoglobinopathiesSEATTLE CHILDRENS HOSPITAL·Filed 2018·Granted Oct 8, 2024·0 cites·18 claims
- 0661US2021052658A1Point-of-care and/or portable platform for gene therapyHUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 0760US12398402B2Reducing CD33 expression to selectively protect therapeutic cellsFRED HUTCHINSON CANCER CENTER·Filed 2019·Granted Aug 26, 2025·0 cites·16 claims
- 0858US11786557B2Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cellsFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Oct 17, 2023·0 cites·19 claims
- 0958US10036039B2Cocal vesiculovirus envelope pseudotyped retroviral vectorsHUTCHINSON FRED CANCER RES·Filed 2017·Granted Jul 31, 2018·0 cites·16 claims
- 1058US2024238438A1CD-90 Targeted Lipid NanoparticlesUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1158US2023313224A1Integration of large adenovirus payloadsFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 1258US2025249125A1Anti-cd90 antibodies, binding fragments, and uses thereofFred Hutchison Cancer Center·Filed 2023·Application pending·0 cites
- 1356US2023330185A1Methods and compositions for transducing hematopoietic stem and progenitor cells in vivoMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1455US2023159895A1Strategies to assess and/or produce cell populations with predictive engraftment potentialFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 1554US2025135039A1Inhibitor-resistant mgmt modifications and modification of mgmt-encoding nucleic acidsENSOMA INC·Filed 2023·Application pending·0 cites
- 1654US2022257796A1Recombinant ad35 vectors and related gene therapy improvementsHUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 1754US2023133243A1Conditioning regimens for in vivo gene therapyFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 1853US2022380776A1Base editor-mediated cd33 reduction to selectively protect therapeutic cellsFRED HUTCHINSON CANCER CENTER·Filed 2020·Application pending·0 cites
- 1952US2025049887A1Methods and compositions for modulating the myeloid arm of the immune systemFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 2048US2016244782A1Cocal vesiculovirus envelope pseudotyped retroviral vectorsHUTCHINSON FRED CANCER RES·Filed 2016·Application pending·0 cites
- 2141US2012164118A1Cocal vesiculovirus envelope pseudotyped retroviral vectorsTROBRIDGE GRANT D·Filed 2010·Application pending·0 cites
- 2239US2020199534A1Therapeutic formulations containing cd34+ stem cells derived from negative selectionHUTCHINSON FRED CANCER RES·Filed 2018·Application pending·0 cites
- 2337US2020009266A1In vivo gene therapy for immune deficienciesHUTCHINSON FRED CANCER RES·Filed 2018·Application pending·0 cites
- 2434US2018127781A1Cocal envelope pseudotyped retroviral vector producer cellsHUTCHINSON FRED CANCER RES·Filed 2016·Application pending·0 cites
- 2533US2019345450A1Strategies to assess and/or produce cell populations with predictive engraftment potentialHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
- 2622US10273503B2Compounds and methods for enhancing viral gene transfer to human hematopoietic cellsUNIVERSTE DE MONTREAL·Filed 2015·Granted Apr 30, 2019·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Hans-Peter Kiem files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →